Use of lopinavir/ritonavir in first-line therapy or second-line therapy: 48-week results from the German prospective STAR cohort

C Koegl1, A Trein2, W Schmidt3, A Baumgarten4, H Jaeger5, HJ Stellbrink6
1MUC Reseach, Munich, Germany
2HIV Center, Stuttgart, Germany
3Aerzteforum Seestraße, Berlin, Germany
4HIV-Practice Berlin Prenzlauerberg, Berlin, Germany
5HIV Research and Clinical Care Centre, Munich, Germany
6ICH (Infektionsmedizinisches Zentrum Hamburg), Hamburg, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo